AIM2 and glioblastoma: In this context, it was observed that the treatment with TTFields led to both AIM2 assembly and activation (Figure 3D) (Table 1) and the induction of the cGAS-STING pathway, both responsible for the membrane-damaged cell death of glioblastoma cancer stem-like cells derived by patients [64].